Jul. 27, 2018—An international team of researchers led by Eric Gamazon has integrated gene expression and disease association data to better understand the biological mechanisms of complex human diseases.
Jul. 19, 2018—Researchers led by James Crowe Jr. are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans. The hope is that the antibodies — like heat-seeking missiles — would seek out and destroy the viruses before they can wreak havoc in the body.
Jul. 12, 2018—In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.
Jul. 12, 2018—A drug used to treat diabetes, liraglutide, may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways.
Jul. 5, 2018—Chronic inflammation is a predisposing condition for colorectal cancer, the third leading cause of cancer-related deaths in the United States. Anna Means, Ph.D., and colleagues have now linked inflammation-driven carcinogenesis in the colon to loss of an important signaling protein called SMAD4.
Jun. 19, 2014—Vanderbilt continues to win recognition for its commitment to helping employees stay healthy, including support for activities that may protect against cancer. Vanderbilt University Medical Center (VUMC), in conjunction with Vanderbilt-Ingram Cancer Center (VICC), has been re-accredited as a CEO Cancer Gold Standard employer for 2014. In 2001, former President George H.W. Bush asked a...